Intravenous formulations of neurokinin-1 antagonists
US9101615B2 · kind B2 · utility
2Cited by
25References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2010 |
| Grant date | Aug 11, 2015 |
| Priority date | — |
| Expiry date | Jul 14, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions for intravenous administration comprising the compound of Formula Ior pharmaceutically acceptable salts, hydrates or prodrugs thereof are described herein. Methods of preparing the pharmaceutical compositions and methods for treating nausea and/or emesis with the pharmaceutical compositions are also described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.